<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01256216</url>
  </required_header>
  <id_info>
    <org_study_id>121509</org_study_id>
    <nct_id>NCT01256216</nct_id>
  </id_info>
  <brief_title>Signature Versus Computer Assisted Surgery Study</brief_title>
  <official_title>A Comparison of Signature Custom Cutting Guides and Computer Assisted Surgery Techniques With the Vanguard Knee System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the data collection is to document the performance and clinical outcomes of&#xD;
      the Vanguard Knee using Signature Custom Cutting Guides and Computer Assisted Surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this prospective clinical data-collection is to document the performance and&#xD;
      clinical outcomes of the Vanguard® Knee System using Signature™ Custom Guides and Computer&#xD;
      Assisted Surgery.&#xD;
&#xD;
      FDA has cleared the Vanguard Knee via premarket notification 510(k) K023546, K033489, and&#xD;
      K050222. FDA has cleared the software for the Signature™ Custom Guides via premarket&#xD;
      notification 510(k) K073449. The data gathered will be collated and used to provide feedback&#xD;
      to design engineers, support marketing efforts, answer potential questions from reimbursement&#xD;
      agencies, and will serve as a part of Biomet's Post Market Surveillance System.&#xD;
&#xD;
      Function will be assessed through the Knee Society Score. Survivorship will be documented by&#xD;
      asking the surgeon to document revisions and complications.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mechanical Alignment</measure>
    <time_frame>Data Collected at 0-10 Weeks; but Analyzed at Completion of Study</time_frame>
    <description>Angle between femoral head, center of knee, and talus.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knee Society Objective Score</measure>
    <time_frame>Completion of Study</time_frame>
    <description>Objective Scoring of Knee Society score is the clinical assessment which includes the sum of range of motion, stability, flexion contracture, extension lag, and alignment scores.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Joint Disease</condition>
  <arm_group>
    <arm_group_label>Signature Custom Cutting Guides</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients receiving a Vanguard Total Knee implanted utilizing non implantable Signature Cutting Guides Surgical Technique.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CAS (Computer Assisted Surgery)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients receiving a Vanguard Total Knee implanted utilizing non implantable Computer Assisted Surgery Technique.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Total Knee Replacement with Vanguard Total Knee</intervention_name>
    <description>Patients indicated for a total knee replacement utilizing the Vanguard Total Knee System.</description>
    <arm_group_label>CAS (Computer Assisted Surgery)</arm_group_label>
    <arm_group_label>Signature Custom Cutting Guides</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Inclusion criteria are identical to the indications for use stated in the FDA cleared&#xD;
             labeling for the device (510(k) K023546, K033489, and K050222).&#xD;
&#xD;
        These indications are stated below:&#xD;
&#xD;
          -  Painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis,&#xD;
             traumatic arthritis where one or more compartments are involved.&#xD;
&#xD;
          -  Correction of varus, valgus, or posttraumatic deformity.&#xD;
&#xD;
          -  Correction or revision of unsuccessful osteotomy, arthrodesis, or failure of previous&#xD;
             joint replacement procedure.&#xD;
&#xD;
          -  The Regenerex™ femoral augments are indicated for use with the Vanguard® Total Knee&#xD;
             System.&#xD;
&#xD;
          -  The Regenerex™ tibial augments are indicated for use with standard and offset Biomet®&#xD;
             Tibial Trays.&#xD;
&#xD;
        Patient selection factors to be considered include:&#xD;
&#xD;
          -  Need to obtain pain relief and improve function&#xD;
&#xD;
          -  Ability and willingness of the patient to follow instructions, including control of&#xD;
             weight and activity level&#xD;
&#xD;
          -  A good nutritional state of the patient, and&#xD;
&#xD;
          -  The patient must have reached full skeletal maturity&#xD;
&#xD;
          -  Femoral components and tibial tray components with porous coatings are indicated for&#xD;
             cemented and uncemented biological fixation application. Non-coated (Interlok™)&#xD;
             devices and all polyethylene patellar components are indicated for cemented&#xD;
             application only.&#xD;
&#xD;
        Exclusion Criteria: Exclusion criteria are identical to the contraindications stated in the&#xD;
        FDA cleared labeling for the device 510(k) K023546, K033489, and K050222. These&#xD;
        contraindications are stated below:&#xD;
&#xD;
          -  Absolute contraindications include: infection, sepsis, and osteomyelitis&#xD;
&#xD;
          -  Relative contraindications include:&#xD;
&#xD;
          -  Uncooperative patient or patient with neurologic disorders who is incapable of&#xD;
             following directions&#xD;
&#xD;
          -  Osteoporosis&#xD;
&#xD;
          -  Metabolic disorders which may impair bone formation,&#xD;
&#xD;
          -  Osteomalacia&#xD;
&#xD;
          -  Distant foci of infections which may spread to the implant site&#xD;
&#xD;
          -  Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram&#xD;
&#xD;
          -  Vascular insufficiency, muscular atrophy, neuromuscular disease&#xD;
&#xD;
          -  Incomplete or deficient soft tissue surrounding the knee.&#xD;
&#xD;
          -  Biomet® Microplasty™ Tibial Trays are contraindicated for use with constrained&#xD;
             bearings.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Russell A Schenck, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Zimmer Biomet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Russells Hall Hospital</name>
      <address>
        <city>Dudley</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>June 2017</verification_date>
  <study_first_submitted>May 12, 2010</study_first_submitted>
  <study_first_submitted_qc>December 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2010</study_first_posted>
  <last_update_submitted>June 16, 2017</last_update_submitted>
  <last_update_submitted_qc>June 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Arthritis</keyword>
  <keyword>Osteoarthritis</keyword>
  <keyword>Arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

